Endocrine Abstracts

Contents

• Oral Presentations
• • Oral Session 1: Topic Highlights
  • • Birth defects in children born to mothers with thyroid disease: biochemical assessment in 20,399 pregnancies substantiates that thyroid function and thyroid autoimmunity are not the causal links

      ea0101op-01-01
    • Reprogramming myeloid bone marrow progenitors in non-medullary thyroid cancer using trained immunity

      ea0101op-01-02
    • Novel Tr-[beta] selective agonist TG68 promotes anti-inflammatory, lipid-lowering and anxiolytic effects

      ea0101op-01-03
    • Unveiling severe adverse events of antithyroid drugs in patients with graves' disease; a real-world multicenter cohort study

      ea0101op-01-04
    • Dabrafenib and trametinib in BRAFV600E anaplastic thyroid cancers: an italian real-word series

      ea0101op-01-05
    • Cut&tag reveals distinct TRA2-specific DNA binding profiles in HIPSC-derived cardiomyocytes

      ea0101op-01-06
  • Oral Session 2: Thyroid hormone action in the brain
  • • Thyroid hormone transporters MCT8 and OATP1C1 exhibit cell-autonomous functions within the oligodendroglia cell lineage in the mouse CNS

      ea0101op-02-01
    • Gestational hypothyroxinemia in dehal1ko mice: discordant T3-dependent gene expression in brain regions and autistic-like phenotype in the offspring

      ea0101op-02-02
    • Thyroid hormone transporters MCT8 and OATP1C1 are required for proper angiogenesis in the mouse CNS

      ea0101op-02-03
    • Exploring the role of TR[beta] in the process of cortical neuron differentiation

      ea0101op-02-04
    • A Novel MCT8 point-mutant mouse model shows effectiveness of phenylbutyrate treatment

      ea0101op-02-05
  • Oral Session 3: Young Investigators/Clinical and Translational
  • • Impact of reclassification of oncocytic and follicular thyroid carcinoma by the 2022 who classification

      ea0101op-03-01
    • Impact of physical activity and its maintenance in the efficacy and safety of tyrosine kinase inhibitors in advanced thyroid carcinoma patients

      ea0101op-03-02
    • Effects of tocilizumab treatment in corticosteroid-resistant graves' orbitopathy

      ea0101op-03-03
    • T3 analogue triiodothyroacetic acid (TRIAC) treatment and survival in MCT8 deficiency: an international real-world cohort study

      ea0101op-03-04
    • Predictors of disease progression in patients with suspicious lymph nodes after initial treatment for thyroid carcinoma

      ea0101op-03-05
    • The association of maternal thyroid function with offspring iq and brain morphology: persistency into early adolescence and relevance of tpoab positivity

      ea0101op-03-06
  • Oral Session 4: Young Investigators/Basic
  • • Identifying novel DIO1 inhibitors to modulate hepatic T3 availability in context of non-alcoholic fatty liver disease

      ea0101op-04-01
    • Thyroid hormone transporters MCT8/OATP1C1 deficient mice exhibit increased seizure susceptibility together with an imbalanced hippocampal neurotransmission

      ea0101op-04-02
    • The role of type 3 deiodinase in a human model for early brain development

      ea0101op-04-03
    • Blood-brain barrier leakage and neurovascular unit ultrastructural alterations as new pathophysiological mechanisms for MCT8 deficiency

      ea0101op-04-04
    • Investigating the role of DICER1 in thyroid tumorigenesis

      ea0101op-04-05
    • Single cell analysis of a thyroid cancer cell line resistant to lenvatinib

      ea0101op-04-06
  • Oral Session 5: Thyroid dysfunction-1
  • • A novel point of care device accurately and rapidely measures thyrotropin in capillary blood

      ea0101op-05-01
    • Exploring the relationship between TSH levels and cardiovascular health in euthyroid individuals: insights from elsa-brasil study

      ea0101op-05-02
    • Cardiovascular risk and mortality in a large italian cohort of patients with resistance to thyroid hormone [beta] (RTH[beta])

      ea0101op-05-03
    • The quality of life impact of weight gain in treated hyperthyroidism

      ea0101op-05-04
    • Effect of the T3 analogue triac on patient-centered outcome measures in patients with MCT8 deficiency: post-hoc analysis of the international triac trial I

      ea0101op-05-05
    • Systematic review of mortality and long-term major cardiovascular events (MACE) following different treatment approaches for hyperthyroidism

      ea0101op-05-06
    • Long-term outcomes of LT4/LT3 combination treatment for persistent hypothyroid symptoms

      ea0101op-05-07
  • Oral Session 6: Translational thyroid cancer research
  • • The role of TPO antibodies in immune escape of aggressive tumors of thyroid follicular cells

      ea0101op-06-01
    • Clinical utility of circulating tumoral dna analysis by multi-gene ngs panels in therapy monitoring of advanced sporadic medullary thyroid carcinoma patients

      ea0101op-06-02
    • Digoxin treatment does not reinduce uptake of radioiodine in metastatic radioiodine refractory non-medullary thyroid carcinoma

      ea0101op-06-03
    • Clinically relevant germline genetic variants and somatic fusions underlying paediatric thyroid cancer risk and aggressiveness

      ea0101op-06-04
    • Molecular profiling of low-risk papillary thyroid carcinomas (MPTC) on active surveillance

      ea0101op-06-05
    • Clinical implications of the gut microbiome in anaplastic thyroid cancer

      ea0101op-06-06
    • Performance of the mir-thype new version algorithm in classification of thyroid indeterminate nodules: latin american multicenter validation study

      ea0101op-06-07
  • Oral Session 7: Thyroid hormone mechanisms in diseases
  • • The protective role of androgen on experimental graves'hyperthyroidism in balb/c mice

      ea0101op-07-01
    • Abrogation of hepatic tr[beta] action attenuates acetaminophen-induced acute liver injury in mice

      ea0101op-07-02
    • Characteristics of hyaluronan metabolism during myofibroblast differentiation in orbital fibroblasts

      ea0101op-07-03
    • Absence of cholesterol gallstone formation in male C57BL/6 mice by abrogation of hepatic thyroid hormone action

      ea0101op-07-04
    • Altered skull and bone morphology in hyperthyroid knock-in mice with TSHR M453T and D633H mutations

      ea0101op-07-05
  • Oral Session 8: Pregnancy
  • • Clinically relevant differences between routinely used immunoassays for thyroid function testing: a danish study of non-pregnant and pregnant adults

      ea0101op-08-01
    • Stimulating TSH-receptor antibodies in early pregnancy using the turbo TSI bioassay: a study of 3,028 pregnant women in the north denmark region

      ea0101op-08-02
    • Detailed morphological phenotyping of maternal thyroid function and offspring brain development: a vertex-wise approach including assessment of gyrification

      ea0101op-08-03
    • Fluid intelligence evaluation through raven's progressive matrices in adult patients with congenital hypothyroidism detected by neonatal screening

      ea0101op-08-04
    • Maternal thyroid function and biochemical markers of placental function in early pregnancy

      ea0101op-08-05
  • Oral Session 9: Basic thyroid cancer research
  • • Epigenetic deregulation and dedifferentiation in thyroid cancer

      ea0101op-09-01
    • TP53 mutations associate with poor response to lenvatinib treatment for advanced thyroid cancer

      ea0101op-09-02
    • Role of the oncogene UHRF1 in thyroid cancer differentiation, progression and response to lenvatinib

      ea0101op-09-03
    • Tumour heterogeneity and evolution in advanced thyroid cancer through multiregion and longitudinal sampling

      ea0101op-09-04
    • Tracing the molecular route to progression in defective mirna biogenesis benign vs malignant thyroid lesions

      ea0101op-09-05
  • Oral Session 10: Thyroid dysfunction-2
  • • Effect of smoking status on TSH receptor antibody (TRAB) levels following treatment for graves' disease

      ea0101op-10-01
    • Towards personalized TSH reference ranges: a genetic and population-based approach in three independent cohorts

      ea0101op-10-02
    • Compensatory rise in TSH when blocking sympathetic activity in cold exposed hunters in east greenland

      ea0101op-10-03
    • The relation between circulating free thyroxine (FT4) and thyroid stimulating hormone (TSH) levels is very different in people taking levothyroxine vs those who are on no thyroid hormone replacement

      ea0101op-10-04
    • Whole-brain computational anatomy in graves' disease: morphometric imprint of pathology and recovery

      ea0101op-10-05
  • Oral Session 11: Molecular Thyroidology
  • • Thyroid Hormone Receptor A1 is a novel regulator of P53 functions

      ea0101op-11-01
    • KLHL14 and its anti-sense lncrna are involved in thyroid cells differentiation

      ea0101op-11-02
    • Molecular mechanisms of triac in the treatment of resistance to thyroid hormone beta (RTH[beta])

      ea0101op-11-03
    • Systematic screening of natural compounds: impacts on thyroid transcriptional activity and NRF1/NRF2 activation

      ea0101op-11-04
    • Perinatal exposure to tbbpa interferes with the establishment of the thyroid axis at young age and the ability to cope with metabolic challenges in adulthood

      ea0101op-11-05
    • Unraveling the genetic landscape of hypothyroidism: insights from a multi-ancestry GWAS meta-analysis

      ea0101op-11-06
    • Hepatocyte-specific DIO3 knockout influences energy metabolism in female mice

      ea0101op-11-07
  • Oral Session 12: Clinical thyroid cancer research
  • • Predictive factors of persistent disease in a large cohort of pediatric patients with differentiated thyroid carcinoma

      ea0101op-12-01
    • Insights from active surveillance: patterns of papillary thyroid carcinoma growth and conversion surgery outcomes

      ea0101op-12-02
    • Patients with medullary thyroid carcinoma and long term treatment with vandetanib: a study from the endocan -tuthyref network

      ea0101op-12-03
    • Pronosthyc: prognostic factors in radioiodine refractory differentiated thyroid cancer with distant metastases, a multicentric study from a french network of referral centers

      ea0101op-12-04
    • Real world outcomes of patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated in 1l with lenvatinib 24 mg: an international multicenter real-world study in europe and canada

      ea0101op-12-05
    • Insight of prospective nora (no radioiodine ablation) study in patients with differentiated thyroid carcinoma (DTC)

      ea0101op-12-06
    • Randomized clinical trial of prophylactic central neck dissection in 2100 papillary thyroid carcinoma patients with clinically negative central neck metastasis: an interim analysis of a single institution

      ea0101op-12-07
  • Oral Session 13: TED
  • • VRDN-003, a full antagonist antibody to IGF-1R for thyroid eye disease (TED): phase 1 results show potential for subcutaneous administration

      ea0101op-13-01
    • Response to teprotumumab is independent of race, ethnicity, and age

      ea0101op-13-02
    • Abstract withdrawn

      ea0101op-13-03
    • Target-tissue immunophenotyping of patients with thyroid eye disease before and after therapy with steroids, tocilizumab and rituximab

      ea0101op-13-04
    • Efficacy of teprotumumab on medical and surgical resistant don

      ea0101op-13-05
    • Prognostic factors and outcomes of intravenous glucocorticoid pulse therapy in moderate-to-severe thyroid eye disease

      ea0101op-13-06
    • Long-term outcome of graves' orbitopathy following treatment with sirolimus (RAPAMYCIN)

      ea0101op-13-07
• Poster Presentations
• • Autoimmunity
  • • Modelling of mechanical stimuli through piezo1 receptor activation and its effect on adipogenic differentiation of orbital fibroblasts

      ea0101ps1-01-01
    • Thyrotropin receptors stimulating antibodies in pediatric patients with graves' disease using ultra-rapid turbo bioassay

      ea0101ps1-01-02
    • Specific patterns of orbital-resident B and T lymphocytes are related to different clinical presentations of thyroid eye disease

      ea0101ps1-01-03
    • Production of chemerin by orbital fibroblasts during myofibroblast and adipocyte differentiation

      ea0101ps1-01-04
    • Interplay between thyroid hormones, liver gene expression, and thyroid eye disease in a murine model of graves' disease

      ea0101ps1-01-05
    • Phenotypical and functional flow cytometry study of natural killer cells in graves' disease

      ea0101ps1-01-06
    • The prevelence of autoimmune thyroidit and the role of regulatory cells in its pathogenesis

      ea0101ps1-01-07
    • In vivo effect of maraviroc, a CCR5 receptor antagonist, on the progression of thyroid eye disease

      ea0101ps1-01-08
  • Anaplastic thyroid cancer
  • • Estrogen-related receptor gamma (ERR[gamma]) as a therapeutic target for anaplastic thyroid cancer and the synergistic killing effect of DN200434 (ERR[gamma] inverse-agonist) and MK2206 (AKT inhibitor) in thyroid cancers

      ea0101ps1-02-01
    • Thyroid fibrosarcoma as a rare differential diagnosis of anaplastic thyroid cancer: a case report

      ea0101ps1-02-02
    • Low dose radiation can improve the therapeutic efficacy of immune checkpoint inhibitor in a mouse anaplastic thyroid cancer model

      ea0101ps1-02-03
    • Progression of papillary thyroid carcinoma to anaplastic carcinoma in metastatic lymph nodes

      ea0101ps1-02-04
    • Clinical and therapeutic particularities of anaplastic thyroid carcinoma

      ea0101ps1-02-05
    • NF1 mutations in anaplastic thyroid cancer: from genetic insights to therapeutic potential

      ea0101ps1-02-06
    • Evaluation of the antineoplastic effect of cabozantinib in primary human cell cultures from anaplastic thyroid carcinoma

      ea0101ps1-02-07
    • Limited efficacy in adding lenvatinib for braf V600E-mutated anaplastic thyroid carcinoma (brafm-atc) progressing on braf-directed therapy

      ea0101ps1-02-08
    • Clinical applicability of liquid biopsy for the management of anaplastic thyroid carcinoma (ATC), a monocentric experience

      ea0101ps1-02-09
    • Liquid biopsy in the follow-up of a patient with braf positive anaplastic thyroid cancer and breast cancer

      ea0101ps1-02-10
  • Thyoid cancer case reports-1
  • • Refractory thyroid carcinoma treated by sorafenib

      ea0101ps1-03-01
    • Two rare cases of benign struma ovarii with malignant recurrence

      ea0101ps1-03-02
    • Rare thyroid gland tumors

      ea0101ps1-03-03
    • Retropharyngeal node metastasis from papillary thyroid carcinoma

      ea0101ps1-03-04
    • Embryo/Fetus dose from [131I]nai therapy during an unsuspected pregnancy

      ea0101ps1-03-05
    • Subacute thyroiditis as the cause of a suspected thyroid nodule

      ea0101ps1-03-06
    • Pregnancy and persistent distant metastases in differentiated thyroid cancer (DTC); a case report

      ea0101ps1-03-07
    • Unusual locations of a pappilary thyroid microcarcinoma

      ea0101ps1-03-08
    • Intrathyroidal parathyroid carcinoma: a case report

      ea0101ps1-03-09
  • Medullary thyroid cancer-1
  • • Comprehensive appearance of men 2a due to CYS634ARG mutation

      ea0101ps1-04-01
    • Trends in the incidence, organization of care, and treatment of medullary thyroid cancer in the netherlands over the last three decades: a population-based study

      ea0101ps1-04-02
    • The intratumoral infiltration of macrophages is associated with concomitant lymphocytic thyroiditis and possibly worse prognosis in patients with medullary thyroid carcinoma

      ea0101ps1-04-03
    • Evidence for the founder effect of V804L and V804M pathogenic variants affected kindred of brazilian families spreading multiple endocrine neoplasia 2A (MEN2A)

      ea0101ps1-04-04
    • Changing the paradigm: lobectomy for sporadic medullary thyroid cancer

      ea0101ps1-04-05
    • C-Cells hyperplasia, what is their role in the development of sporadic medullary cancer?

      ea0101ps1-04-06
    • Can haemithyroidectomy be an adequate treatment for nonhereditary medullary thyroid cancer (MTC)?

      ea0101ps1-04-07
    • Medullary and papillary thyroid carcinoma presenting as a collision tumors in the thyroid: report of seven cases

      ea0101ps1-04-08
    • Somatostatin analogues treatment in a patient suffering from a sporadic bifocal ret-negative medullary thyroid cancer with extended extrathyroidal spread after three surgical interventions

      ea0101ps1-04-09
    • Clinical value of preoperative calcitonin for the prediction of distant metastases in patients with medullary thyroid carcinoma

      ea0101ps1-04-10
  • Clinical thyroid cancer research-1
  • • preexisting diabetes and aggressiveness of thyroid cancer: a cross sectional analysis

      ea0101ps1-05-01
    • Serum anti-thyroglobulin antibody levels following total thyroidectomy are related to the recurrence of papillary thyroid carcinoma

      ea0101ps1-05-02
    • Toxicity and quality of life after locoregional radiotherapy in patients with thyroid cancer

      ea0101ps1-05-03
    • Reproductive concern and intention in young female patients with differentiated thyroid cancer after thyroidectomy: a prospective cohort study

      ea0101ps1-05-04
    • Impact of lymph node metastases features on presentation and outcome of patients with differentiated thyroid carcinoma (DTC)

      ea0101ps1-05-05
    • Data-driven thyroglobulin cutoffs for low- and intermediate-risk differentiated thyroid cancer follow-up in a real-world setting

      ea0101ps1-05-06
    • Thyroidectomized patients on LT-4 therapy with advanced medullary thyroid carcinoma treated with selpercatinib show peculiar variations of thyroid function tests

      ea0101ps1-05-07
    • Pediatric differentiated thyroid carcinoma: radioiodine treatment in hypothyroidism or after recombinant TSH?

      ea0101ps1-05-08
    • Bone mineral density (BMD), bone turnover markers (BTMS) and evaluation of musculoskeletal system in patients with differentiated thyroid cancer undergoing TSH suppressive therapy

      ea0101ps1-05-09
    • Differentiated thyroid carcinoma: preliminary results of a randomized clinical trial on the impact of transitioning care to primary healthcare supported by telemedicine

      ea0101ps1-05-10
  • Thyroid cancer treatment
  • • Intraoperative neuromonitoring does not decrease the risk of vocal cord palsy associated with thyroid cancer surgeries, but cumulative experience over time may

      ea0101ps1-06-01
    • Impact of short lenvatinib interruptions in advanced thyroid cancer patients

      ea0101ps1-06-02
    • Risk factors predicting papillary thyroid cancer recurrence: a single-surgeon experience

      ea0101ps1-06-03
    • Radiofrequency ablation (RFA) for structural incomplete response (SIR) to therapy in differentiated thyroid cancer (DTC)

      ea0101ps1-06-04
    • Counselling of thyroid cancer patients, what patient need to know from surgeon about treatment options, complications & follow-up

      ea0101ps1-06-05
    • Molecular profile can influence the PFS in radioiodine-refractory thyroid cancer patients treated with lenvatinib

      ea0101ps1-06-06
    • The role of primary non-selective laryngeal reinnervation in the treatment of invasive thyroid cancer

      ea0101ps1-06-07
    • Can nocturnal administration of lenvatinib based on time pharmacology reduce adverse events?

      ea0101ps1-06-08
    • Surgical management of medullary thyroid carcinoma with tracheal invasion

      ea0101ps1-06-09
    • The risk of hypocalcemia in total thyroidectomy with comprehensive mediastinal-recurrent cellular and lymph-node dissection

      ea0101ps1-06-10
  • Case reports
  • • Intrathyroidal osseous metaplasia mimicking thyroid nodule suspicious for malignancy in a female patient with graves' disease- a case report

      ea0101ps1-07-01
    • Liothyronine and a sudden unexplained death: cause or coincidence?

      ea0101ps1-07-02
    • Methimazol-induced hepatitis in a patient with graves' disease

      ea0101ps1-07-03
    • Combined immune checkpoint inhibitor therapy and onset of graves' hyperthyroidism followed by seroconversion to autoimmune hypothyroidism: a case report

      ea0101ps1-07-04
    • Thyroid diagnostic dilemmas

      ea0101ps1-07-05
    • Differential diagnostic challenges for ophthalmic diseases: a case report

      ea0101ps1-07-06
    • Patient concurrent hashimoto thyroiditis, hypothyroidism and graves orbitopathy

      ea0101ps1-07-07
    • Giant paracardial thyroid ectopy causing graves' hyperthyroidism. clinical and histological findings

      ea0101ps1-07-08
    • A case of thyrotoxic periodical paralysis in a caucasian subject

      ea0101ps1-07-09
  • Hyperthyroidism
  • • Refractory case of amiodarone-induced thyrotoxicosis in a high cardiovascular risk patient

      ea0101ps1-08-01
    • Prevalence of metabolic syndrome and its components in patients with controlled graves' disease

      ea0101ps1-08-02
    • High frequency of mental fatigue after treatment of graves' hyperthyroidism but low rate of sick-leave - report from a longitudinal cohort in sweden

      ea0101ps1-08-03
    • Thymic hyperplasia is accurate to detect new onset graves' hyperthyroidism and resolves after restoring euthyroidism

      ea0101ps1-08-04
    • Trab levels and thyroid volume in graves' disease treated with block-replace therapy versus titration regimen

      ea0101ps1-08-05
    • Healthcare professionals' experiences of caring for patients with graves disease- an interview study

      ea0101ps1-08-06
    • Quality of life in graves disease: does type of treatment matter?

      ea0101ps1-08-07
    • Contrast-enhanced ultrasound (CEUS) in hyperthyroid diffuse diseases

      ea0101ps1-08-08
    • Quality of life after thyroidectomy for benign thyroid disease

      ea0101ps1-08-09
  • Nodules
  • • Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules smaller than 10 mm in the maximum diameter: the efficacy and its correlation with tirads classification

      ea0101ps1-09-01
    • Acromegaly and thyroid nodules: a retrospective, single-centre, real-world observational study

      ea0101ps1-09-02
    • Clinical utility of artificial intelligence in follow up of thyroid thermal ablative therapy for benign thyroid nodules

      ea0101ps1-09-03
    • Application of shear wave elastography (SWE) in the management of thyroid nodules in children and adolescents

      ea0101ps1-09-04
    • Predictive factors in patients rejected for radiofrequency ablation of cytologically benign thyroid nodules: an observational cohort study

      ea0101ps1-09-05
    • Gender-based disparities in clinical presentation and outcomes of benign thyroid nodules

      ea0101ps1-09-06
    • Active surveillance of bethesda iv nodules

      ea0101ps1-09-07
    • Natural course of benign thyroid nodules

      ea0101ps1-09-08
    • Role of elastography in the differentiation of thyroid versus parathyroid lesions

      ea0101ps1-09-09
    • Changes of thyroid volume after iodine supplementation: preliminary data

      ea0101ps1-09-10
  • Intracellular effects of TH
  • • Type 3 deiodinase is a negative prognostic marker for hepatocarcinoma

      ea0101ps2-10-01
    • Non-genomic effects of thyroid hormones on the breast cancer microenvironment

      ea0101ps2-10-02
    • Thyroid hormone receptor [alpha] is involved in pro- and anti-inflammatory properties of murine macrophages

      ea0101ps2-10-03
    • Unravelling the role of MCT8 in early brain development

      ea0101ps2-10-04
    • Exploring the molecular mechanisms underlying radiation-induced thyroid damage using an organoid model

      ea0101ps2-10-05
    • The role of thyroid hormone receptor A1 (TRA1) signaling in parvalbumin-expressing interneurons in the central regulation of the cardiovascular system and anxiety-like behavior

      ea0101ps2-10-06
    • Brain abnormalities in young mice harboring combined NKX2-1 and PAX8 gene mutations

      ea0101ps2-10-07
    • Regulation of hepatic mitochondrial quality control system by 3,5-diiodo-l-thyronine (3,5-t2) in a mouse model of high-fat diet-induced nafld

      ea0101ps2-10-08
    • Exploring the role of DIO2 in the control of proliferation and cell fate determination in adult neural progenitors

      ea0101ps2-10-09
    • Impact of triiodothyronine (T3) on differentiation and T3-responsive characteristics in ipsc-derived hepatocyte-like cells to study energy and lipid metabolism

      ea0101ps2-10-10
  • Basic thyroid cancer research-1
  • • Anti-proliferative and anti-migratory activity of licorice extract and glycyrrhetinic acid on papillary thyroid cancer cultures

      ea0101ps2-11-01
    • Maldi-ms imaging in niftp diagnosis: an alternative approach

      ea0101ps2-11-02
    • Generation of medullary thyroid cancer ex-vivo cellular models

      ea0101ps2-11-03
    • Downregulation of MIR-346 affects the expression of nuclear receptor-interacting protein 1 (NRIP-1) and estrogen receptors in follicular thyroid cancer

      ea0101ps2-11-04
    • Fusion partner agnostic approaches improve detection of targetable gene fusions in thyroid cancers

      ea0101ps2-11-05
    • The autonomic system balance and integrin AVB related molecular markers in patients with papillary thyroid carcinoma

      ea0101ps2-11-06
    • Effects of crizotinib in strn-alk anaplastic thyroid cancer in primary culture in vitro

      ea0101ps2-11-07
    • TSHR variants in benign and malignant thyroid tumors

      ea0101ps2-11-08
    • Dual agonism of sodium iodide symporter function in vivo

      ea0101ps2-11-09
    • Exploring the genetic links between voltage-gated potassium channels and familial non-medullary thyroid carcinoma: a family study

      ea0101ps2-11-10
  • Diagnosis of thyroid cancer-1
  • • The clinical significance of markedly elevated preoperative serum thyroglobulin levels

      ea0101ps2-12-01
    • Performance of eu-tirads, ATA and AACE/ACE-AME ultrasound risk stratification system (RSS) in pediatric patients with thyroid nodules

      ea0101ps2-12-02
    • Differences and analogies in thyroid cancer discovered incidentally or by thyroid related screening: a multicenter study

      ea0101ps2-12-03
    • Markers of aggressiveness in radioiodine-refractory thyroid cancer

      ea0101ps2-12-04
    • Comparative analysis of thyroid cytopathology preparation: conventional smear, liquid-based preparation, and their combination

      ea0101ps2-12-05
    • A comparative study between the old and the new version of a microrna and dna-based molecular classifier for indeterminate thyroid nodules in real-world samples

      ea0101ps2-12-06
    • Molecular profiling of thyroid nodules: insights from the mir-thype full trial in brazilian patients

      ea0101ps2-12-07
    • Appropriately positioned molecular testing for cytologically indeterminate thyroid nodules in an optimized thyroid nodule diagnostic pathway has incremental impact in addition to clinical assessment, cytology and ultrasound malignancy risk

      ea0101ps2-12-08
    • A combined approach TI-RADS and ceus in detecting thyroid cancer

      ea0101ps2-12-09
    • A multi-center study of malignancy risk stratification of indeterminate thyroid fine needle aspiration cytologies based on mirna expression

      ea0101ps2-12-10
  • Medullary thyroid cancer-2
  • • Clinical and molecular analysis of a MEN2A kindred harboring the rare RET variant p.ser904phe

      ea0101ps2-13-01
    • Basal calcitonin needs the help of stimulation test for the diagnosis of sporadic medullary thyroid cancer (MTC) only in selected cases

      ea0101ps2-13-02
    • Role of procalcitonin in unmasking false hypercalcitoninemia

      ea0101ps2-13-03
    • Sporadic medullary thyroid carcinoma: about 17 cases

      ea0101ps2-13-04
    • Molecular characterization of circulating tumor cells (CTCS) in sporadic medullary thyroid carcinoma (SPMTC) patients

      ea0101ps2-13-05
    • The impact of preoperative calcitonin screening on the prognosis of patients with medullary thyroid cancer: a retrospective multicenter cohort study

      ea0101ps2-13-06
    • Unraveling the prevalence and clinical behavior or sporadic apparently non-invasive medullary thyroid carcinoma

      ea0101ps2-13-07
    • Usefulness of extensive germline ret testing in apparently sporadic medullary thyroid cancer

      ea0101ps2-13-08
    • Index cases of familial medullary thyroid carcinoma show different clinical presentation and outcome compared to sporadic cases

      ea0101ps2-13-09
    • Pathological and molecular characterization of peritumoral desmoplasia in medullary thyroid carcinoma

      ea0101ps2-13-10
  • Clinical thyroid cancer research-2
  • • High concordance in intuitive vs standardized assessment of whole-body scintigraphy after radioiodine therapy for thyroid cancer

      ea0101ps2-14-01
    • Tracking dynamic evolution of low- and intermediate-risk differentiated thyroid cancer. identification of individuals at risk of recurrence

      ea0101ps2-14-02
    • Impact of presence of psammoma bodies on long-term prognosis in papillary thyroid carcinoma cases

      ea0101ps2-14-03
    • Subcutaneous neck metastases from thyroid cancer: a series of six cases diagnosed and followed-up in a single center

      ea0101ps2-14-04
    • Real life experience of a single center in the treatment of metastatic rai refractory (RAI-R) differentiated thyroid carcinoma (DTC)

      ea0101ps2-14-05
    • Postoperative basal serum thyroglobulin and need for radioiodine in patients with low to intermediate-risk papillary thyroid cancer

      ea0101ps2-14-06
    • Differentiated thyroid cancer in children: a single institution experience of 7 years

      ea0101ps2-14-07
    • Needle tract seeding of thyroid cancer after biopsy of distant metastasis: a retrospective cohort study

      ea0101ps2-14-08
    • Predictive factors determining incomplete response to initial radioiodine therapy in patients with papillary thyroid microcarcinoma

      ea0101ps2-14-09
    • Are we able to preoperatively predict low-risk thyroid cancer? a retrospective analysis of preoperative ultrasound in large group of patients

      ea0101ps2-14-10
  • Translational thyroid cancer research-1
  • • Development of a molecular quantum chemistry-based pipeline combined with publicly available datasets and robust open-source bioinformatics tools that indicate variations in redox balance genes that may have diagnostic and prognostic significance in thyroid cancer

      ea0101ps2-15-01
    • Expression of HSA-MIR-139-5P as a clinically feasible prognostic marker for thyroid cancer

      ea0101ps2-15-02
    • Genomic profiling of metastases from papillary and poorly differentiated thyroid carcinomas

      ea0101ps2-15-03
    • Usefulness of metabolomic analyses in the pre surgical evaluation of thyroid nodules

      ea0101ps2-15-04
    • BRAF mutation is associated with tumor volume doubling time of thyroid microcarcinoma during active surveillance

      ea0101ps2-15-05
    • Methionyl-trna synthetase 1 expression as a diagnosis and prognosis factor in papillary thyroid cancer

      ea0101ps2-15-06
    • Analysis of the impact of oncocytic cells on the performance of the thyroid molecular classifier based on micrornas and DNA: results from the optimized version of the MIR-thype test

      ea0101ps2-15-07
    • How (respiratory) air can complement the diagnosis of thyroid changes - a pilot study using ion mobility spectrometry

      ea0101ps2-15-08
    • Impact of genomic biomarkers on treatment decisions and clinical outcomes in patients with radioiodine-refractory thyroid cancer and treatment with multi-tyrosine kinase inhibitors - a multi-center registry analysis

      ea0101ps2-15-09
    • Abstract withdrawn

      ea0101ps2-15-10
  • Diagnostics and Populations Studies
  • • A review on impediments related to the legislation and implementation regarding iodine deficiency disorders in pakistan; a lesson for other nations

      ea0101ps2-16-01
    • Increased psychological distress among patients with thyroid diseases during COVID-19 pandemic: the epitome study

      ea0101ps2-16-02
    • Management of central hypothyroidism in geriatric patient with panhypopituitarism due to pituitary apoplexy

      ea0101ps2-16-03
    • Association of thyroid peroxidase antibodies and high-sensitivity c-reactive protein in men and women: a cross-sectional analysis from the elsa-brasil study

      ea0101ps2-16-04
    • Nadh fluorescence in the skin is a novel biomarker of hypothyroidism-associated impairment of energy metabolism

      ea0101ps2-16-05
    • Very low rates of thyroid function testing in human studies evaluating basal metabolic rate

      ea0101ps2-16-06
    • Iodine intake and thyroid diseases in adult subject from different geographical regions of croatia

      ea0101ps2-16-07
    • Acquired hypothyroidism, iodine status and hear impairment in adults

      ea0101ps2-16-08
    • Thyroid function and incidence of increased carotid intima-media thickness: results from elsa-brasil cohort study

      ea0101ps2-16-09
    • Diagnostic role of thyroid elastography in graves' disease

      ea0101ps2-16-10
  • Non-surgical treatment
  • • Predictive factors for success of radioactive iodine treatment in graves' disease

      ea0101ps2-17-01
    • Efficacy of radioactive iodine treatment in graves' disease using a calculated 131i dose in a portuguese cohort

      ea0101ps2-17-02
    • Abstract withdrawn

      ea0101ps2-17-03
    • Efficacy of intrathyroidal dexamethasone injection in steroid-dependent subacute thyroiditis - preliminary report of dlisat study

      ea0101ps2-17-04
    • J-131 therapy in patients with autonomously functioning thyroid nodules and normal FT4 blood level

      ea0101ps2-17-05
    • Proficiency in performing radiofrequency ablation procedure for non-functioning benign thyroid nodules: a qualitative rather than quantitative matter

      ea0101ps2-17-06
    • Abstract withdrawn

      ea0101ps2-17-07
    • Laser thermal ablation for benign thyroid nodules: a single polish centre experience

      ea0101ps2-17-08
    • Safety and efficacy of ultrasound-guided thrombin injection for pseudoaneurysms arising after ultrasound-guided biopsy of thyroid nodules

      ea0101ps2-17-09
    • Prevalence and ultrasonography features of thyroglossal duct cyst in adults according to radioactive iodine ablation

      ea0101ps2-17-10
  • Pregnancy
  • • Changes of central sensitivity to thyroid hormones during pregnancy

      ea0101ps2-18-01
    • Iodine status in pregnant women with hashimoto's thyroiditis: is iodine supplementation needed?

      ea0101ps2-18-02
    • Thyroid function in pregnancy in normal weight and obese women without thyroid diseases

      ea0101ps2-18-03
    • Mild & moderate iodine deficiency in pregnant women from sub-himalayan regions of india: impact on thyroid status

      ea0101ps2-18-04
    • Trimester specific thyroid hormone reference range in mild iodine deficiency compared to normal iodine nutrition

      ea0101ps2-18-05
    • Iodine status in a population-based cohort study of a multiethnic pregnant women in norway

      ea0101ps2-18-06
    • An innovative method to better understand thyroid function changes: longitudinal trajectories of gestational thyroid function

      ea0101ps2-18-07
    • Iodine availability from prenatal supplements in portugal

      ea0101ps2-18-08
    • Maternal urinary iodine concentration and thyroid function in the offspring: preliminary results of an italian multicenter study

      ea0101ps2-18-09
    • Thyroid and fertility: a survey on the clinical practice among endocrinologists belonging to the italian thyroid association (AIT)

      ea0101ps2-18-10
  • TED
  • • Analysis of thyroid stimulating immunoglobulins vs conventional TSH-receptor antibodies in clinical practice

      ea0101ps2-19-01
    • In vivo and in vitro evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in graves' orbitopathy

      ea0101ps2-19-02
    • The association of the cholesterol metabolic profile and fatty acid content with the clinical phenotype of graves' orbitopathy

      ea0101ps2-19-03
    • Analytical performance of a novel bioassay for blocking thyrotropin receptor antibodies

      ea0101ps2-19-04
    • Lymphocytes' immunophenotype guided treatment in a thyroid eye disease patient successfully treated with rituximab

      ea0101ps2-19-05
    • Graves orbitopathy, does all the patients evolve in the same way?

      ea0101ps2-19-06
    • Duration of treatment for thyroid eye disease

      ea0101ps2-19-07
    • Management of thyroid eye disease (TED) related strabismus in euthyroid patient with with negative anti thyroid antibodies

      ea0101ps2-19-08
    • A marker of inflammatory state and the clinical outcome of active go to parenteral glucocorticoids

      ea0101ps2-19-09
    • Abstract withdrawn

      ea0101ps2-19-10
  • Thyroid function, feedback & disruptors
  • • A new mouse model to better decipher the minimum proportion of active follicles required to sustain normal thyroid function

      ea0101ps3-20-01
    • Overview of traditional chinese medicine for hashimoto's thyroiditis: focus on selenium and antioxidant phytochemicals

      ea0101ps3-20-02
    • Variable sensitivity of thyroid hormone feedback in different zebrafish models of thyroid dysfunction

      ea0101ps3-20-03
    • Identification of eukaryotic translation initiation factor 4b as a novel candidate gene for congenital hypothyroidism

      ea0101ps3-20-04
    • Investigating the safety and NRF2 activation of a sulforaphane-generating supplement through drinking water in mice across thyroid and other tissues

      ea0101ps3-20-05
    • Optimization of the spatial transcriptomics technology to explore the combined effect of a perinatal exposure to TBBPA and western diet at adult age on the unique transcriptomic signature of the different hypothalamic NUCLEI

      ea0101ps3-20-06
    • Dissecting oxidation-dependent and oxidation-independent components of thyroid autoregulation

      ea0101ps3-20-07
    • Exposure to an EDC mixture disrupts thyroid function in mice in a sex specific manner

      ea0101ps3-20-08
    • Identification of markers for thyroid signaling disruption by transcriptomic analysis in teleost fish and amphibian

      ea0101ps3-20-09
  • Thyoid cancer case reports-2
  • • A rare thyroid cancer - case report of a follicular thyroid lymphoma

      ea0101ps3-21-01
    • A case of bilateral chylothorax after a total thyroidectomy and left sided modified radical neck dissection for papillary thyroid cancer

      ea0101ps3-21-02
    • Autonomous thyroid hormone production in metastatic follicular cancer - a case report

      ea0101ps3-21-03
    • Papillary thyroid carcinoma arising within a mature ovarian cystic teratoma: a case report

      ea0101ps3-21-04
    • Massive thrombosis of the internal jugular vein by a thyroid gland carcinoma

      ea0101ps3-21-05
    • Metastasis to the thyroid gland: a rare etiology of thyroid nodules associated with malignant neoplasms

      ea0101ps3-21-06
    • An innovative way of administration of radioactive iodine in an 11 years' old girl with intellectual disability after total thyroidectomy for differentiated thyroid cancer

      ea0101ps3-21-07
    • Epidural metastases revealing differentiated thyroid cancer: a case report

      ea0101ps3-21-08
    • Papillary thyroid cancer (PTC) Coexisting with thyroid tuberculosis: about cases

      ea0101ps3-21-09
    • Atypical metastasis of follicular thyroid carcinoma

      ea0101ps3-21-10
  • Diagnosis of thyroid cancer-2
  • • Ultrasonographic features predicting lateral cervical lymph node metastases in patients with papillary thyroid microcarcinoma

      ea0101ps3-22-01
    • Fine needle aspiration cytology in the diagnosis of thyroid nodules

      ea0101ps3-22-02
    • Cost-effectiveness of diagnosis by ultrasound for asymptomatic thyroid cancer in south korea

      ea0101ps3-22-03
    • The value of acr, european, korean and ATA ultrasound risk stratification systems combined with ras mutations for detecting thyroid carcinoma in cytologically indeterminate and suspicious for malignancy thyroid nodules

      ea0101ps3-22-04
    • Efficacy of machine learning model in predicting thyroid malignancy risk

      ea0101ps3-22-05
    • Diagnostic and prognostic roles of perioperative F18-FDG PET/CT for differentiated thyroid cancer

      ea0101ps3-22-06
    • Predicting extrathyroidal extension (ETE) of differentiated thyroid carcinoma (DTC) preoperatively by using ultrasonography (US)

      ea0101ps3-22-07
    • [18F]fluorocholine positron emission tomography/computed tomography characterization of hyperfunctioning and hypofunctioning benign thyroid nodules

      ea0101ps3-22-08
    • Predictive value of quantitative indexes of FDG pet in the evaluation of thyroid nodules

      ea0101ps3-22-09
    • Characteristics of bethesda 3 and 4 thyroid nodules: bethesda grey area

      ea0101ps3-22-10
    • Complexities and challenges in the diagnosis and management of borderline thyroid tumors

      ea0101ps3-22-11
  • Clinical thyroid cancer research-3
  • • Real-life levothyroxine intake with possible restriction of absorption in thyroid cancer patients

      ea0101ps3-23-01
    • Thyroid nodules in children

      ea0101ps3-23-02
    • DICER1-associated thyroid tumour families

      ea0101ps3-23-03
    • Distinguishing follicular-type thyroid carcinomas from their benign counterparts, a study of 104 consecutively resected and needle-biopsied tumors

      ea0101ps3-23-04
    • Clinicopathological characteristics and outcome of patients with poorly differentiated thyroid cancer-a single center experience

      ea0101ps3-23-05
    • Overweight as a risk factor for concomitant thyroid cancer in graves' disease patients: a retrospective study

      ea0101ps3-23-06
    • Early detection and management of hypocalcaemia after total thyroidectomy

      ea0101ps3-23-07
    • Association between diabetes mellitus and molecular profile in papillary thyroid carcinoma patients: a retrospective study

      ea0101ps3-23-08
    • Thyroid cancer associated with hashimoto thyroidits : pronostic outcomes

      ea0101ps3-23-09
    • Abstract withdrawn

      ea0101ps3-23-10
  • Translational thyroid cancer research-2
  • • HIF-1[alpha] inhibitors could successfully inhibit the progression of differentiated thyroid cancer

      ea0101ps3-24-01
    • Non-genetic risk factors for thyroid cancer an umbrella review of evidence

      ea0101ps3-24-02
    • Thyroid differentiation score (TDS) can differentiate between malignant and benign thyroid neoplasms

      ea0101ps3-24-03
    • Comparison of mutational profiles between papillary thyroid microcarcinoma with central neck lymph nodes and without central neck lymph nodes

      ea0101ps3-24-04
    • Potential influence of MIR-204-3P on ETS-1 protein expression in papillary thyroid carcinoma

      ea0101ps3-24-05
    • Molecular profiling of advanced thyroid cancer: characterizing tumors for targeted treatment

      ea0101ps3-24-06
    • DNA methylation in the thyroid tumors with known gene alteration

      ea0101ps3-24-07
    • No responsiveness of the thyroid to protective effects of melatonin against chromium-induced oxidative damage - comparison to the ovary and non-endocrine tissues

      ea0101ps3-24-08
    • Use of liquid biopsy in metastatic differentiated thyroid cancer: paving the way of precision management

      ea0101ps3-24-09
    • Association between single nucleotide polymorphisms and disease aggressiveness in patients with papillary thyroid cancer. do we have a new diagnostic tool?

      ea0101ps3-24-10
  • Hypothyroidism
  • • Understanding levothyroxine dosage adjustments after bariatric surgery

      ea0101ps3-25-01
    • A national randomized placebo-controlled double-blind multicenter trial of LT4/lT3 combination therapy in patients with autoimmune hypothyroidism: T3-4-hypo trial

      ea0101ps3-25-02
    • Rapid levothyroxine absorption test: results in 143 refractory hypothyroid patients treated with oral levothyroxine

      ea0101ps3-25-03
    • Riedel's thyroiditis: report of 7 patients

      ea0101ps3-25-04
    • Autoimmune hypothyroidism incidence in a large population-based study in northeastern italy

      ea0101ps3-25-05
    • Breakfast habits in patients using levothyroxine: a questionnaire survey on patient experiences and preferences

      ea0101ps3-25-06
    • Effect of bariatric surgery on tsh levels and levothyroxine dosage in patients with thyroid disease: sleeve gastrectomy vs roux-en-y gastric bypass

      ea0101ps3-25-07
    • Circulating tsh levels are more stable in patients with hypothyroidism treated with liquid L-T4

      ea0101ps3-25-08
    • Potential risks and benefits of desiccated thyroid extract for the treatment of hypothyroidism: a systematic review

      ea0101ps3-25-09
    • Rebound effect in hypothalamic-pituitary thyreotropic activity: a new model to better understand hypothyroidism and hormonal replacement therapies

      ea0101ps3-25-10
  • Miscellaneous
  • • Parathyroid adenoma : radiologic features and correlation study with ^99mTc-sestamibi spect findings

      ea0101ps3-26-01
    • Calcitonin levels and pseudohypoparathyroidism: understanding the connection

      ea0101ps3-26-02
    • Thyrolipoma and thyrolipmatosis

      ea0101ps3-26-03
    • Association between thyroid function and periodontitis

      ea0101ps3-26-04
    • Evaluation of topical hemostatic agents (THA) used in perioperative period in thyroidectomy patients: assessment of ultrasonographic characteristics, resolution durations, and potential long-term complications

      ea0101ps3-26-05
    • Obesity related hypoventilation syndrome in patients with hypothyroidism

      ea0101ps3-26-06
  • Thyroid and Genetics
  • • Identification of a stat3 mutation, P.THR716MET in two cases of very early-onset autoimmune hypothyroidism

      ea0101ps3-27-01
    • New insights in the diagnosis and treatment of allan-herndon-dudley syndrome

      ea0101ps3-27-02
    • Thyroid hormone resistance in an infant harboring a novel de novo mutation of the thrb gene

      ea0101ps3-27-03
    • The whole-genome DNA methylation pattern in peripheral white blood cells in adults and children with graves' disease

      ea0101ps3-27-04
    • Thyroid hormone analogue (TRIAC) therapy in resistance to thyroid hormone beta, reduces hyperthyroid symptoms, lowers circulating thyroid hormones and metabolic rate effectively, without adverse effects

      ea0101ps3-27-05
    • Decoding SLC26A7'S role in congenital hypothyroidism: delayed onset, very large goiters, and thyrotropin dependent basolateral expression

      ea0101ps3-27-06
    • The incidence of multinodular goiter in patients with DICER1 syndrome and the risk of cancer

      ea0101ps3-27-07
    • Unique features of resistance to thyroid hormone alpha due to a homozygous mutation in thra

      ea0101ps3-27-08
    • Intergenerational anticipation of disease onset in families with autoimmune thyroid disease

      ea0101ps3-27-09
  • Treatment – surgery
  • • clinical impact of pectoral nerve ii block on postoperative pain, opioid usage, and patient recovery experience in robot-assisted transaxillary thyroidectomy: a prospective, randomized controlled trial

      ea0101ps3-28-01
    • Total thyroidectomy and quality of life in patients with hashimoto thyroiditis, a scoping review

      ea0101ps3-28-02
    • Pre-thyroidectomy vitamin d&calcium administration to prevent hypocalcemia: a systematic review

      ea0101ps3-28-03
    • Establishing transoral thyroid and parathyroid endoscopic vestibular approach (toetva-toepva) service in the united kingdom national health system: the safe road to success

      ea0101ps3-28-04
    • Comparison of voice outcome according to the degree of thyroidectomy

      ea0101ps3-28-05
    • Emergency surgery for post-thyroidectomy hematoma: a life saving procedure

      ea0101ps3-28-06
    • Thyroid operation under local anesthesia in bangladesh, how & when i do

      ea0101ps3-28-07
    • Robotic transaxillary surgery -a scarless safe option for thyroid surgery

      ea0101ps3-28-08
    • A short course of lugol's solution in toxic nodular thyroid disease: a pre-post intervention study on thyroid hormones and quality of life

      ea0101ps3-28-09
    • Extent of surgery in the surgical treatment of graves' disease: subtotal vs. total thyroidectomy and comparison of the long-term results

      ea0101ps3-28-10